Besides, the therapeutic potential of IGF-1 in diseases characterized by impaired hippocampal function needs to be better investigated, especially considering evidence pointing to brain insulin and IGF-1 resistance in Alzheimer's disease patients [94]. Here, IGF1 is linked to early-onset autosomal dominant Alzheimer disease.